KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Bio-Rad Laboratories (BIO) Total Debt (2016 - 2026)

Bio-Rad Laboratories has reported Total Debt over the past 18 years, most recently at $802.9 million for Q1 2026.

  • Quarterly Total Debt fell 33.13% to $802.9 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $802.9 million through Mar 2026, down 33.13% year-over-year, with the annual reading at $1.2 billion for FY2025, 0.11% changed from the prior year.
  • Total Debt was $802.9 million for Q1 2026 at Bio-Rad Laboratories, down from $1.2 billion in the prior quarter.
  • Over five years, Total Debt peaked at $1.2 billion in Q4 2025 and troughed at $802.9 million in Q1 2026.
  • The 5-year median for Total Debt is $1.2 billion (2023), against an average of $1.2 billion.
  • Year-over-year, Total Debt skyrocketed 11291.63% in 2022 and then plummeted 33.13% in 2026.
  • A 5-year view of Total Debt shows it stood at $1.2 billion in 2022, then rose by 0.12% to $1.2 billion in 2023, then rose by 0.11% to $1.2 billion in 2024, then rose by 0.11% to $1.2 billion in 2025, then crashed by 33.19% to $802.9 million in 2026.
  • Per Business Quant, the three most recent readings for BIO's Total Debt are $802.9 million (Q1 2026), $1.2 billion (Q4 2025), and $1.2 billion (Q3 2025).